Literature DB >> 12111117

Immature myeloid cells and cancer-associated immune suppression.

Sergei Kusmartsev1, Dmitry I Gabrilovich.   

Abstract

Impaired balance between mature and immature myeloid cells is one of the hallmarks of cancer. In cancer patients as well as in mouse models there is increasing evidence that progressive tumor growth is associated with an accumulation of immature myeloid cells, monocytes/macrophages, and with a decreased number and function of dendritic cells (DC). This review examines recent findings on the contribution of immature myeloid cells (ImC) to cancer-induced immune suppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111117     DOI: 10.1007/s00262-002-0280-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  104 in total

1.  Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.

Authors:  Chun-Te Wu; Ching-Chuan Hsieh; Cheng-Chia Lin; Wen-Cheng Chen; Ji-Hong Hong; Miao-Fen Chen
Journal:  J Mol Med (Berl)       Date:  2012-06-03       Impact factor: 4.599

Review 2.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  Oncoantigens for an immune prevention of cancer.

Authors:  Elisabetta Bolli; Elena Quaglino; Maddalena Arigoni; Pier-Luigi Lollini; Raffaele Calogero; Guido Forni; Federica Cavallo
Journal:  Am J Cancer Res       Date:  2010-12-20       Impact factor: 6.166

4.  Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck.

Authors:  Yvonne K Mburu; Koji Abe; Laura K Ferris; Saumendra N Sarkar; Robert L Ferris
Journal:  Carcinogenesis       Date:  2010-11-11       Impact factor: 4.944

5.  Comparison of immunologic outcomes of laparoscopic vs open approaches in clinical stage III colorectal cancer.

Authors:  Sang-Ah Han; Woo Yong Lee; Chi-Min Park; Seong Hyeon Yun; Ho-Kyung Chun
Journal:  Int J Colorectal Dis       Date:  2010-02-23       Impact factor: 2.571

6.  Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.

Authors:  Güllü Topal Görgün; Gregory Whitehill; Jennifer L Anderson; Teru Hideshima; Craig Maguire; Jacob Laubach; Noopur Raje; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

7.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.

Authors:  Sally A DuPré; Doug Redelman; Kenneth W Hunter
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

8.  Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model.

Authors:  Guangfu Li; Dai Liu; Timothy K Cooper; Eric T Kimchi; Xiaoqiang Qi; Diego M Avella; Ningfei Li; Qing X Yang; Mark Kester; C Bart Rountree; Jussuf T Kaifi; David J Cole; Don C Rockey; Todd D Schell; Kevin F Staveley-O'Carroll
Journal:  J Hepatol       Date:  2016-08-09       Impact factor: 25.083

9.  Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Authors:  Stanimir Vuk-Pavlović; Peggy A Bulur; Yi Lin; Rui Qin; Carol L Szumlanski; Xinghua Zhao; Allan B Dietz
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

10.  Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.

Authors:  Zoya B Kurago; Aroonwan Lam-ubol; Anton Stetsenko; Chris De La Mater; Yiyi Chen; Deborah V Dawson
Journal:  Head Neck Pathol       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.